The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5S,7aS)-1-(3,5-bis(trifluoromethyl)phenyl)-5-((R)-4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl)tetrahydro-1H-pyrrolo[1,2-c]imidazol-3(2H)-one ID: ALA4756749
PubChem CID: 117850098
Max Phase: Preclinical
Molecular Formula: C31H26F10N2O2
Molecular Weight: 648.54
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(F)c(C(C)C)cc1-c1ccc(C(F)(F)F)cc1[C@@H]1CC[C@H]2[C@@H](c3cc(C(F)(F)F)cc(C(F)(F)F)c3)NC(=O)N12
Standard InChI: InChI=1S/C31H26F10N2O2/c1-14(2)20-12-22(26(45-3)13-23(20)32)19-5-4-16(29(33,34)35)11-21(19)24-6-7-25-27(42-28(44)43(24)25)15-8-17(30(36,37)38)10-18(9-15)31(39,40)41/h4-5,8-14,24-25,27H,6-7H2,1-3H3,(H,42,44)/t24-,25-,27+/m0/s1
Standard InChI Key: NQSTVUFUSFYCMP-OHSXHVKISA-N
Molfile:
RDKit 2D
46 50 0 0 0 0 0 0 0 0999 V2000
24.6973 -22.2086 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.1195 -21.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9039 -22.4242 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.7940 -19.4021 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.5835 -20.1987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3750 -19.9847 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.7299 -16.1333 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.7340 -15.3120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0201 -15.7170 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.5555 -15.3183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9581 -16.0272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7721 -16.0300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1844 -15.3245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7727 -14.6149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9601 -14.6156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3236 -14.6029 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.1859 -16.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1697 -17.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0025 -16.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4564 -18.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8487 -17.4977 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1402 -17.9035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3127 -18.7030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1252 -18.7885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5330 -19.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1221 -20.2081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5295 -20.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3517 -20.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7648 -20.2044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3510 -19.4956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9966 -20.9129 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.2986 -21.6300 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.0358 -18.6221 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
25.0057 -15.3259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4116 -16.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2321 -16.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6468 -15.3288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2309 -14.6139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4117 -14.6157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0017 -13.9047 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.4088 -13.1921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4681 -15.3290 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
26.6434 -16.7532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2291 -17.4641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4647 -16.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3898 -17.5705 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 1 0
6 5 1 0
8 7 1 0
9 8 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
10 8 1 0
8 16 1 0
17 21 1 0
20 18 1 0
18 19 1 0
19 17 1 0
17 12 1 6
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 20 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 25 1 0
24 25 1 1
29 5 1 0
5 31 1 0
27 2 1 0
2 32 1 0
20 33 1 6
13 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 34 1 0
39 40 1 0
40 41 1 0
37 42 1 0
36 43 1 0
43 44 1 0
43 45 1 0
22 46 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 648.54Molecular Weight (Monoisotopic): 648.1835AlogP: 9.65#Rotatable Bonds: 5Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.01CX Basic pKa: ┄CX LogP: 8.68CX LogD: 8.67Aromatic Rings: 3Heavy Atoms: 45QED Weighted: 0.28Np Likeness Score: -0.24
References 1. Liu J,Shao PP,Guiadeen D,Krikorian A,Sun W,Deng Q,Cumiskey AM,Duffy RA,Murphy BA,Mitra K,Johns DG,Duffy JL,Vachal P. (2021) Cholesteryl ester transfer protein (CETP) inhibitors based on cyclic urea, bicyclic urea and bicyclic sulfamide cores., 32 [PMID:33161125 ] [10.1016/j.bmcl.2020.127668 ] 2. Vachal P, Duffy JL, Campeau LC, Amin RP, Mitra K, Murphy BA, Shao PP, Sinclair PJ, Ye F, Katipally R, Lu Z, Ondeyka D, Chen YH, Zhao K, Sun W, Tyagarajan S, Bao J, Wang SP, Cote J, Lipardi C, Metzger D, Leung D, Hartmann G, Wollenberg GK, Liu J, Tan L, Xu Y, Chen Q, Liu G, Blaustein RO, Johns DG.. (2021) Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties., 64 (18.0): [PMID:34375108 ] [10.1021/acs.jmedchem.1c00959 ]